GlassScriptPhysician profile
Michael Xiong
NPI 1245627439
$464.14
in general payments reported to CMS, 2019-2025
14 companies · $17.51 in 2025
The $17.51 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $88.99 · 2021: $118 · 2024: $239 · 2025: $17.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $114.91 | 2020-2024 | Tremfya, Simponi Aria, Stelara |
| Organogenesis INC. | $78.62 | 2024 | |
| Genzyme Corporation | $46.72 | 2021 | |
| Lilly USA, LLC | $38.05 | 2021-2024 | Ebglyss, Taltz |
| Abbvie INC. | $34.31 | 2024-2025 | |
| Ucb, INC. | $26.65 | 2024 | Bimzelx |
| Leo Pharma INC. | $23.20 | 2024 | Adbry |
| Pfizer INC. | $19.45 | 2021 | |
| Biofrontera INC. | $16.99 | 2020 | |
| Arcutis Biotherapeutics, INC. | $14.02 | 2024 | Zoryve |
| Novartis Pharmaceuticals Corporation | $13.71 | 2021 | |
| Misonix INC | $13.18 | 2021 | |
| Organon LLC | $12.31 | 2024 | |
| Helsinn Therapeutics (U.S.), INC. | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Xiong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.